Xiangning M. Qiu

Changsha, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Fractional Radiofrequency Microneedling Is Associated With Improved Clinical Outcomes in Chinese Patients With Axillary Bromhidrosis: A Multicenter Single-Arm Prospective Study.

Fractional Radiofrequency Microneedling Is Associated With Improved Clinical Outcomes in Chinese Patients With Axillary Bromhidrosis: A Multicenter Single-Arm Prospective Study.

Journal: Journal of the American Academy of Dermatology

Published: June 19, 2026

Influential Factors in the Efficacy and Safety of Hemoporfin-Mediated Photodynamic Therapy for Facial Port-Wine Stains.

Influential Factors in the Efficacy and Safety of Hemoporfin-Mediated Photodynamic Therapy for Facial Port-Wine Stains.

Journal: Journal of cosmetic dermatology

Published: November 21, 2024

The construction of HMME-PDT efficacy prediction model for port-wine stain based on machine learning algorithms.

The construction of HMME-PDT efficacy prediction model for port-wine stain based on machine learning algorithms.

Journal: Scientific reports

Published: November 19, 2024

Silica's silent threat: Contributing to skin fibrosis in systemic sclerosis by targeting the HDAC4/Smad2/3 pathway.

Silica's silent threat: Contributing to skin fibrosis in systemic sclerosis by targeting the HDAC4/Smad2/3 pathway.

Journal: Environmental pollution (Barking, Essex : 1987)

Published: January 23, 2024

MiR-4769-3p suppresses adipogenesis in systemic sclerosis by negatively regulating the USP18/VDAC2 pathway.

MiR-4769-3p suppresses adipogenesis in systemic sclerosis by negatively regulating the USP18/VDAC2 pathway.

Journal: iScience

Published: October 14, 2023

Sirtuin 1 overexpression contributes to the expansion of follicular helper T cells in systemic lupus erythematosus and may serve as an accessible therapeutic target.

Sirtuin 1 overexpression contributes to the expansion of follicular helper T cells in systemic lupus erythematosus and may serve as an accessible therapeutic target.

Journal: Rheumatology (Oxford, England)

Published: April 15, 2023

ATRA ameliorates fibrosis by suppressing the pro-fibrotic molecule Fra2/AP-1 in systemic sclerosis.

ATRA ameliorates fibrosis by suppressing the pro-fibrotic molecule Fra2/AP-1 in systemic sclerosis.

Journal: International immunopharmacology

Published: March 05, 2023

Overexpressed perforin contributes to the melanocyte destruction via epigenetic regulation in patients with vitiligo.

Overexpressed perforin contributes to the melanocyte destruction via epigenetic regulation in patients with vitiligo.

Journal: International immunopharmacology

Published: November 04, 2022

UVA1 irradiation attenuates collagen production via Ficz/AhR/MAPK signaling activation in scleroderma.

UVA1 irradiation attenuates collagen production via Ficz/AhR/MAPK signaling activation in scleroderma.

Journal: International immunopharmacology

Published: October 21, 2022

Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases.

Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases.

Journal: Current medicinal chemistry

Published: September 06, 2022

Bullous lichen sclerosus-generalized morphea overlap syndrome improved by tofacitinib.

Bullous lichen sclerosus-generalized morphea overlap syndrome improved by tofacitinib.

Journal: Dermatologic therapy

Published: June 26, 2022

Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR/Smad2/3 signaling.

Esomeprazole alleviates fibrosis in systemic sclerosis by modulating AhR/Smad2/3 signaling.

Journal: Pharmacological research

Published: October 03, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026